Abstract
Transcobalamin (TC) transports cobalamin from blood into cells. TC deficiency is a rare autosomal recessive disorder usually presenting in early infancy with failure to thrive, weakness, diarrhoea, pallor, anemia, and pancytopenia or agammaglobulinemia. It can sometimes resemble neonatal leukemia or severe combined immunodeficiency disease. Diagnosis of TC deficiency is suspected based on megaloblastic anemia, elevation of total plasma homocysteine, and blood or urine methylmalonic acid. It is confirmed by studying the synthesis of TC in cultured fibroblasts, or by molecular analysis of the TCN2 gene. TC deficiency is treatable with supplemental cobalamin, but the optimal type, route and frequency of cobalamin administration and long term patient outcomes are unknown. Here we present a series of 30 patients with TC deficiency, including an update on multiple previously published patients, in order to evaluate the different treatment strategies and provide information about long term outcome. Based on the data presented, current practice appears to favour treatment of individuals with TC deficiency by intramuscular injections of hydroxy- or cyanocobalamin. In most cases presented, at least weekly injections (1 mg IM) were necessary to ensure optimal treatment. Most centres adjusted the treatment regimen based on monitoring CBC, total plasma homocysteine, plasma and urine methylmalonic acid, as well as, clinical status. Finally, continuing IM treatment into adulthood appears to be beneficial.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aitelli C, Wasson L, Page R (2004) Pernicious anemia: presentations mimicking acute leukemia. South Med J 97(3):295–297
Arlet JB, Varet B, Besson C (2002) Favorable long-term outcome of a patient with transcobalamin II deficiency. Ann Intern Med 137(8):704–705
Arrabal MC, Villegas A, Mariscal E, Lentijo B, Luck W, Hoffbrand AV (1988) Transcobalamin II deficiency: long-term follow-up of two cases. Acta Haematol 80(3):162–166
Bibi H, Gelman-Kohan Z, Baumgartner ER, Rosenblatt DS (1999) Transcobalamin II deficiency with methylmalonic aciduria in three sisters. J Inherit Metab Dis 22(7):765–772
Burman JF, Mollin DL, Sourial NA, Sladden RA (1979) Inherited lack of transcobalamin II in serum and megaloblastic anaemia: a further patient. Br J Haematol 43(1):27–38
Carmel R, Ravindranath Y (1984) Congenital transcobalamin II deficiency presenting atypically with a low serum cobalamin level: studies demonstrating the coexistence of a circulating transcobalamin I (R binder) complex. Blood 63(3):598–605
Grech V, Vella C, Mercieca V (2001) Temporary myoclonus with treatment of congenital transcobalamin 2 deficiency. Pediatr Neurol 24(1):75–76
Gururangan S, Frankel W, Broaddus R et al (2008) Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation. Neuro Oncol 10(1):93–97
Häberle J, Pauli S, Berning C, Koch HG, Linnebank M (2009) TC II deficiency: avoidance of false-negative molecular genetics by RNA-based investigations. J Hum Genet 54(6):331–334
Hall CA (1992) The neurological aspects of transcobalamin II deficiency. Br J Haematol 80:117–120
Hitzig WH, Dohmann U, Pluss HJ, Vischer D (1974) Hereditary transcobalamin II deficiency: clinical findings in a new family. J Pediatr Nov 85(5):622–628
Kaikov Y, Wadsworth LD, Hall CA, Rogers PC (1991) Transcobalamin II deficiency: case report and review of the literature. Eur J Pediatr 150(12):841–843
Li N, Rosenblatt DS, Kamen BA, Seetharam S, Seetharam B (1994a) Identification of two mutant alleles of transcobalamin II in an affected family. Hum Mol Genet 3(10):1835–1840
Li N, Rosenblatt DS, Seetharam B (1994b) Nonsense mutations in human transcobalamin II deficiency. Biochem Biophys Res Comm 204:1111–1118
Mayes JS, Say B, Marcus DL (1987) Prenatal studies in a family with transcobalamin II deficiency. Am J Hum Genet 41(4):686–687
Namour F, Olivier J, Abdelmouttaleb I et al (2001) Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 97(4):1092–1098
Namour F, Helfer AC, Quadros EV et al (2003) Transcobalamin deficiency due to activation of an intra exonic cryptic splice set. Br J Haematol 123:915–920
Nissen PH, Nordwall M, Hoffmann-Lücke E, Sorensen BS, Nexo E (2010) Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents. J Inherit Metab Dis 33(Suppl 3):269–274
Prasad C, Rosenblatt DS, Corley K, Cairney AE, Rupar CA (2008) Transcobalamin (TC) deficiency–potential cause of bone marrow failure in childhood. J Inherit Metab Dis 31(Suppl 2):S287–S292
Prasad C, Cairney AE, Rosenblatt DS, Rupar CA (2012) Transcobalamin (TC) deficiency and newborn screening. J Inherit Metab Dis 35(4):727
Rana SR, Colman N, Goh KO, Herbert V, Klemperer MR (1983) Transcobalamin II deficiency associated with unusual bone marrow findings and chromosomal abnormalities. Am J Hematol 14(1):89–96
Ratschmann R, Minkov M, Kis A et al (2009) Transcobalamin II deficiency at birth. Mol Genet Metab 98(3):285–288
Schiff M, Ogier de Baulny H, Bard G et al (2010) Should transcobalamin deficiency be treated aggressively? J Inherit Metab Dis 33:223–229
Souied EH, Benhamou N, Sterkers M et al (2001) Retinal degeneration associated with congenital transcobalamin II deficiency. Arch Ophthalmol 119:1076–1077
Thomas PK, Hoffbrand AV (1997) Hereditary transcobalamin II deficiency: a 22 year follow up. J Neurol Neurosurg Psychiatry 62(2):197
Thomas PK, Hoffbrand AV, Smith IS (1982) Neurological involvement in hereditary transcobalamin II deficiency. J Neurol Neurosurg Psychiatry 45(1):74–77
Watkins D, Rosenblatt DS (2011a) Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet 157(1):33–44
Watkins D, Rosenblatt DS (2011) Inherited disorders of folate and cobalamin transport and metabolism, In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, eds. The Online Metabolic and Molecular Bases of Inherited Disease, 8th edn. Chap 155, on-line, McGraw-Hill, New-York
Zeitlin HC, Sheppard K, Baum JD, Bolton FG, Hall CA (1985) Homozygous transcobalamin II deficiency maintained on oral hydroxocobalamin. Blood 66(5):1022–1027
Acknowledgments
Roger Dewar and Jennifer Kelly performed the DNA analyses in Dr. Rupar’s laboratory
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Matthias Baumgartner
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 28 kb)
Rights and permissions
About this article
Cite this article
Trakadis, Y.J., Alfares, A., Bodamer, O.A. et al. Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis 37, 461–473 (2014). https://doi.org/10.1007/s10545-013-9664-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-013-9664-5